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Introduction
The incidence of CDI has increased substantially during the
past decade. C. difficile is now one of the most important
causes of healthcare-associated infections. Antimicrobial
use is the primary risk factor for CDI. Several small studies
have assessed whether fluoroquinolones increase the risk of
CDI more than other antimicrobials.
Objectives
To systematically review and evaluate all published stu-
dies on the relationship between fluoroquinolone use
and CDI.
Methods
We performed systematic literature searches in PubMed,
Wiley’s Cochrane Database of Systematic Reviews (CDSR),
Wiley’s Database of Abstracts of Reviews of Effects
(DARE), Wiley’s Cochrane Central Register of Controlled
Trials (CENTRAL), Scopus (including EMBASE abstracts),
and http://ClinicalTrials.gov. We ran the searches on
October 15, 2012 with no limits on date or language. We
used a random-effects model to obtain meta-analysis sum-
mary estimates. After reviewing 431 article abstracts and
reviewing 22 articles in detail, we pooled risk estimates
from 17 independent study populations.
Results
When we pooled the crude data from all 17 studies in a
random-effects model, fluoroquinolone use was signifi-
cantly associated with a higher risk of CDI than other
antimicrobials (pooled OR: 2.93; 95% CI: 2.12, 4.05).
Twelve of 17 studies provided adjusted risk estimates.
When we pooled the adjusted data, fluoroquinolone use
remained a significant risk factor for CDI, albeit with a
lower pooled OR (pooled OR: 1.71; 95% CI: 1.48, 1.96).
Conclusion
Fluoroquinolone use was associated with increased risk
of CDI compared with other antimicrobials. Antibiotic
stewardship campaigns to limit to overuse of fluoroqui-
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